Profounda
5790 Hoffner Avenue
Suite 507
Orlando
Florida
32822-4824
United States
Tel: 800-407-6810
Website: http://www.profounda.com/
Email: info@profounda.com
About Profounda
Profounda is a product-oriented, privately backed pharmaceutical company that aims to develop high quality specialty niche pharmaceutical products in both the branded and generic pharmaceutical markets. As a team of highly qualified industry experts, our objective is to focus on bringing high quality innovative options to patients being treated for various conditions at competitive prices in order to improve the lives of those that take our medication.LEADERSHIP:
CEO: Todd MacLaughlan
5 articles about Profounda
-
Profounda Launches Rhinase Baby Lubricating Nasal Drops
1/24/2018
Profounda announced today that Rhinase Baby Lubricating Nasal Drops is now available in the United States through Rhinase.com and Amazon.com as well as on retail shelves at Kinney Drugs. Patients can also ask their Pharmacists to order Rhinase products directly from Profounda or Cardinal Health.
-
FDA Grants Profounda Orphan Drug Designation For Treatment Of Granulomatous Amebic Encephalitis (GAE) With Miltefosine
6/28/2017
-
Profounda Receives FDA Orphan-Drug Designation For The Treatment Of Primary Amebic Meningoencephalitis (PAM) With Miltefosine
12/19/2016
-
FDA Orphan Drug Designation Granted To Profounda For The Treatment Of Acanthamoeba Keratitis With Miltefosine
12/19/2016
-
Orlando Patient Survives Primary Amebic Meningoencephalitis (PAM) Using Profounda's Drug Impavido (Miltefosine)
8/24/2016